Study shows gender bias persists in performance-driven industry
Women in the investment profession face a double standard even when objective information on their performance is available.
Improving care transitions for patients
A new Yale study offers strategies to enhance the care of Medicare patients who move to a nursing facility after a hospitalization for an acute illness.
Treating depression: an expert discusses risks, benefits of ketamine
Dr. Gerard Sanacora expains why ketamine is so helpful for people with severe depression and possible future applications for the drug.
Lower brain glucose levels found in people with obesity, type 2 diabetes
The finding might explain disordered eating behavior — and even a higher risk of Alzheimer’s disease — among obese and diabetic individuals, say researchers.
Mobile devices may determine how places and people increase HIV risk
Federal funding will allow researchers to develop methods to accurately assess the effects of GPS tracking and cell phone monitoring on HIV risk behavior.
Patient navigators address barriers to health care
The Yale Patient Navigator Program pairs teams of medical students with patients from Yale’s primary care clinics who face serious social barriers to health.
Yale discovery indicates potential for new types of cancer drugs
Yale Cancer Center scientists have made a fundamental discovery about EGFR signaling that may open the potential for new types of cancer drugs.